These interactions further reinforce the hypothesis that hormonal signaling, particularly via ERα and ERβ, contributes to the immune landscape of NSCLC by modulating PD-L1 expression through multiple, context-dependent molecular pathways. Here, ESR2 is linked to non-small cell lung carcinoma.